This is a page describing data taken during an experiment at the ISIS Neutron and Muon Source. Information about the ISIS Neutron and Muon Source can be found at https://www.isis.stfc.ac.uk.
Membrane interactions and drug distribution of lipidic nanocapsules
Abstract: Retinal diseases are often progressive conditions that worsen over time, potentially causing permanent vision impairment. There are several retinal disorders, including neurodegenerative diseases of the retina, which are still lacking a valid treatment. As new classes of drugs are developed to tackle retinal degeneration, a suitable carrier system is essential for delivery of the drug to the retinal tissues. Lipidic nanocapules (LNCs) are thought to enable delivery of drug to the retinal tissue after intravitreal injection, but it is not clear if the LNCs interact with the cell membrane and if this is important for the delivery of the drug to the retina. In the study proposed here, the goal is to take a first step in understanding the mechanistic interaction of LNCs with mammalian cell membrane models, which will inform improved formulation development and modification of drug release.
Principal Investigator: Dr Sara Malekkhaiat Häffner
Experimenter: Mr Dileep Urimi
Local Contact: Dr Maxmilian Skoda
Experimenter: Miss Ida Cederwall
DOI: 10.5286/ISIS.E.RB2210096
ISIS Experiment Number: RB2210096
Part DOI | Instrument | Public release date | Download Link |
---|---|---|---|
10.5286/ISIS.E.RB2210096-1 | OFFSPEC | 04 July 2025 | Download |
Publisher: STFC ISIS Neutron and Muon Source
Data format: RAW/Nexus
Select the data format above to find
out more about it.
Data Citation
The recommended format for citing this dataset in a research
publication is as:
[author], [date], [title], [publisher],
[doi]
For Example:
Dr Sara Malekkhaiat Häffner et al; (2022): Membrane interactions and drug distribution of lipidic nanocapsules, STFC ISIS Neutron and Muon Source, https://doi.org/10.5286/ISIS.E.RB2210096
Data is released under the CC-BY-4.0 license.